541 results on '"Rubba, Paolo"'
Search Results
2. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial
3. The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
4. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study
5. Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia
6. Abstract 14407: The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
7. Abstract 14267: Evinacumab Lowers LDL-C in Patients With Homozygous Familial Hypercholesterolemia Irrespective of Background Lipid-lowering Medication
8. Abstract 14270: The Effect of Evinacumab on Apheresis Eligibility in Patients With Homozygous Familial Hypercholesterolemia
9. Markers of subclinical atherosclerosis in patients with aortic valve sclerosis: A meta-analysis of literature studies
10. A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort
11. Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests
12. Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis
13. Vascular Complications of Homocystinuria: Incidence, Clinical Pattern and Treatment
14. Nutrition and Antioxidants
15. Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study
16. Homocysteine and Vascular Disease: The European Concerted Action Project
17. Association between Non-HDL-C/HDL-C Ratio and Carotid Intima–Media Thickness in Post-Menopausal Women
18. Abstract 12066: The Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
19. Abstract 12027: Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia Who Participated in Sequential Studies of Alirocumab and Evinacumab
20. Hemodynamic Changes after Acute Cholesterol Reduction: Mechanisms and Mediators
21. The effect of evinacumab on LDL-C goal attainment in patients with homozygous familial hypercholesterolemia
22. Carotid Atherosclerosis, Ultrasound and Lipoproteins
23. Tumor necrosis factor- α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome
24. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena
25. The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family
26. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
27. Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children
28. Effects of Atorvastatin on the Different Phases of Atherogenesis
29. Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial
30. Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests
31. Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena)
32. Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy
33. Early Atherosclerotic Lesions in Childhood and Adolescence
34. Evinacumab for Homozygous Familial Hypercholesterolemia
35. Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study
36. Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels
37. A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia
38. Carotid Artery Remodeling in Middle-Aged Women With the Metabolic Syndrome (from the “Progetto ATENA” Study)
39. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project
40. Lowering blood lipids to treat atherosclerosis: Vascular tone, plaques, events, and mortality
41. Vascular Complications of Homocystinuria: Incidence, Clinical Pattern and Treatment
42. Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial
43. Increased Carotid Intima-Media Thickness and Stiffness in Obese Children
44. Differential Effects of Body Adiposity and Serum Lipids on Right and Left Carotid Artery Lesions: Response
45. Association of Obesity and Central Fat Distribution With Carotid Artery Wall Thickening in Middle-Aged Women
46. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: Relationship with obesity
47. Regarding “High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women”
48. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
49. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study
50. Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.